IL10 and diabetes mellitus: Improved bacterial killing was observed in PBMCs treated with anti-IL-10 prior to infection with B. pseudomallei in both healthy individuals and individuals with DM (Fig. 7a; p < 0.05 and Fig. 7b; p < 0.001 respectively), compared to those without IL-10 neutralization.